translational medicine


Why Hasn't Clinical Genetics Taken Off?

Insiders to genomics are looking around and, generally over a tasty adult beverage, bemoan the lack of forward progress on the clinical side of adoption. Why haven clinical adoption rates gone up faster? What’s making this hard? I’ve become frustrated over the last few years, raising a significant amount of money across a number of companies, all trying to speed up the scale of adoption in the non-sick population. Looking back, looking around and seeing how the current landscape of startups and new activities in clinical genetics are being run, I’ve come to the following conclusions.

Joint Summit on Bioinformatics

Guests:

Dr. Neil Sarkar, Director, Biomedical Informatics, University of Vermont

Listen Listen (17:00) - Bio and Contact Info

Dr. Philip Payne, Dept. Chair, Biomedical Informatics, The Ohio State University

Dr. Philip Payne Listen (21:14) - Bio and Contact Info

Dr. Russ Altman, Dept Chair, Bioengineering, Stanford University

Dr. Russ Altman Listen (25:34) - Bio and Contact Info

 

The field of Biomedical informatics has been around for a long time. But with the great output of genetic and genomic data and the recent push to create electronic medical records, the world of bioinformatics is greatly expanding and gaining in popularity. In early March we attended the Joint Summit for Translational Bioinformatics and Clinical Research Informatics. At the show, I sat down with the conference chairs for each of these sides of the show to discuss this exciting and emerging field.



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup